These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 37556076)
21. Identification of immune-related gene signature predicting survival in the tumor microenvironment of lung adenocarcinoma. Zhao M; Li M; Chen Z; Bian Y; Zheng Y; Hu Z; Liang J; Huang Y; Yin J; Zhan C; Feng M; Wang Q Immunogenetics; 2020 Dec; 72(9-10):455-465. PubMed ID: 33188484 [TBL] [Abstract][Full Text] [Related]
22. Identification and analysis of prognostic immune cell homeostasis characteristics in lung adenocarcinoma. Sun Y; Ma Q; Chen Y; Liao D; Kong F Clin Respir J; 2024 May; 18(5):e13755. PubMed ID: 38757752 [TBL] [Abstract][Full Text] [Related]
23. The Combined Detection of Immune Genes for Predicting the Prognosis of Patients With Non-Small Cell Lung Cancer. Tian WJ; Liu SS; Li BR Technol Cancer Res Treat; 2020; 19():1533033820977504. PubMed ID: 33256552 [TBL] [Abstract][Full Text] [Related]
24. G0 arrest gene patterns to predict the prognosis and drug sensitivity of patients with lung adenocarcinoma. Ma Y; Li Z; Li D; Zheng B; Xue Y PLoS One; 2024; 19(8):e0309076. PubMed ID: 39159158 [TBL] [Abstract][Full Text] [Related]
25. Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung Adenocarcinoma. Huang Z; Li B; Guo Y; Wu L; Kou F; Yang L Front Immunol; 2021; 12():723172. PubMed ID: 34539658 [TBL] [Abstract][Full Text] [Related]
26. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma. Wu P; Zheng Y; Wang Y; Wang Y; Liang N J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329 [TBL] [Abstract][Full Text] [Related]
27. Prognostic Cell Death Index for Lung Adenocarcinoma: A Comprehensive Transcriptome-Based Analysis of Twelve Programmed Cell Death Pattern Genes. Chen F; Ma J; Hu S; Wu C; Chen S; Lin J Front Biosci (Landmark Ed); 2024 Apr; 29(4):135. PubMed ID: 38682187 [TBL] [Abstract][Full Text] [Related]
28. A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma. Zou X; Hu Z; Huang C; Chang J Med Sci Monit; 2020 Jul; 26():e924269. PubMed ID: 32613949 [TBL] [Abstract][Full Text] [Related]
29. An exosomes-related lncRNA prognostic model correlates with the immune microenvironment and therapy response in lung adenocarcinoma. Chu D; Chen L; Li W; Zhang H Clin Exp Med; 2024 May; 24(1):104. PubMed ID: 38761234 [TBL] [Abstract][Full Text] [Related]
30. Heat shock factor 5 correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma. Aizemaiti R; Wu Z; Tang J; Yan H; Lv X Int J Med Sci; 2021; 18(2):448-458. PubMed ID: 33390814 [TBL] [Abstract][Full Text] [Related]
31. Construction and Validation of a Tumor Microenvironment-Based Scoring System to Evaluate Prognosis and Response to Immune Checkpoint Inhibitor Therapy in Lung Adenocarcinoma Patients. Huang P; Xu L; Jin M; Li L; Ke Y; Zhang M; Zhang K; Lu K; Huang G Genes (Basel); 2022 May; 13(6):. PubMed ID: 35741714 [TBL] [Abstract][Full Text] [Related]
32. Identification Six Metabolic Genes as Potential Biomarkers for Lung Adenocarcinoma. Zhang S; Lu Y; Liu Z; Li X; Wang Z; Cai Z J Comput Biol; 2020 Oct; 27(10):1532-1543. PubMed ID: 32298601 [TBL] [Abstract][Full Text] [Related]
33. Identification and validation of tryptophan-related gene signatures to predict prognosis and immunotherapy response in lung adenocarcinoma reveals a critical role for PTTG1. Wang Z; Zhang J; Zuo C; Chen H; Wang L; Xie Y; Ma H; Min S; Wang X; Lian C Front Immunol; 2024; 15():1386427. PubMed ID: 39144144 [TBL] [Abstract][Full Text] [Related]
34. A Novel Nucleic Acid Sensing-related Genes Signature for Predicting Immunotherapy Efficacy and Prognosis of Lung Adenocarcinoma. Peng X; Wu H; Zhang B; Xu C; Lang J Curr Cancer Drug Targets; 2024; 24(4):425-444. PubMed ID: 37592781 [TBL] [Abstract][Full Text] [Related]
35. Seven interferon gamma response genes serve as a prognostic risk signature that correlates with immune infiltration in lung adenocarcinoma. Yao B; Wang L; Wang H; Bao J; Li Q; Yu F; Zhu W; Zhang L; Li W; Gu Z; Fei K; Zhang P; Zhang F; Huang X Aging (Albany NY); 2021 Apr; 13(8):11381-11410. PubMed ID: 33839701 [TBL] [Abstract][Full Text] [Related]
36. Construction of an immune-related lncRNA signature pair for predicting oncologic outcomes and the sensitivity of immunosuppressor in treatment of lung adenocarcinoma. Zhuang J; Chen Z; Chen Z; Chen J; Liu M; Xu X; Liu Y; Yang S; Hu Z; He F Respir Res; 2022 May; 23(1):123. PubMed ID: 35562727 [TBL] [Abstract][Full Text] [Related]
37. Gefitinib metabolism-related lncRNAs for the prediction of prognosis, tumor microenvironment and drug sensitivity in lung adenocarcinoma. Guo Z; Zhang X; Yang D; Hu Z; Wu J; Zhou W; Wu S; Zhang W Sci Rep; 2024 May; 14(1):10348. PubMed ID: 38710798 [TBL] [Abstract][Full Text] [Related]
38. Identification of immune activation-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma. Zeng W; Wang J; Yang J; Chen Z; Cui Y; Li Q; Luo G; Ding H; Ju S; Li B; Chen J; Xie Y; Tong X; Liu M; Zhao J Front Immunol; 2023; 14():1217590. PubMed ID: 37492563 [TBL] [Abstract][Full Text] [Related]
39. Microenvironment Analysis of Prognosis and Molecular Signature of Immune-Related Genes in Lung Adenocarcinoma. Ling B; Huang Z; Huang S; Qian L; Li G; Tang Q Oncol Res; 2021 Mar; 28(6):561-578. PubMed ID: 32471520 [TBL] [Abstract][Full Text] [Related]
40. Prognostic and immunological implications of glutathione metabolism genes in lung adenocarcinoma: A focus on the core gene SMS and its impact on M2 macrophage polarization. Qiu J; Wang Z; Yu Y; Zheng Y; Li M; Lin C Int Immunopharmacol; 2024 May; 132():111940. PubMed ID: 38593503 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]